(R)-N,N-Dimethyl-1-(morpholin-2-yl)methanamine, 95+%, 1g

(E)-4,4,5,5-Tetramethyl-2-(2-methylstyryl)-1,3,2-dioxaborolane, 95+%, 1g

1,4-oxazepan-5-one, 98.0%, 25g

tert-Butyl (3-iodopropyl)carbamate, 95.0%, 1g

Narrow mouth bottle 301, 200 ml, 18 mm, 10 Piece(s)

1-(5-Hydroxypyridin-2-yl)ethanone, 95.0%, 25g

[1,4'-Bipyridin]-1-ium chloride hydrochloride, 95.0%, 25g

4-[(2-Methyl-2-propen-1-yl)oxy]benzaldehyde, 95.0%, 5g

5-chloro-1,3-dimethyl-1H-1,2,4-triazole, 95.0%, 10g

Dodecamethylcyclohexasiloxane, 95%, 100g

2-[(2-furylmethyl)amino]-7-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde, 95.0%, 1g

(E)-3-(3,5-DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-1-YL)PHENYL)ACRYLIC ACID, 95%, 10mg

6-CHLORO-7-(2-FLUOROBENZYL)-7H-PURINE, 90.0%, 1g